DV
Dividend Vision

ANRO — Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (ANRO)

Total return is 100.9% over the past 2.5 years, 37.4 points ahead of SPY at 63.5%. Its deepest 1-year drawdown was 34.2%.

Alto Neuroscience, Inc. is an equity fund focused on neuroscience-related assets. The fund lacks a specified distribution frequency and yield profile, with limited publicly available data on its expense ratio and assets under management.

ANRO key facts

Asset type
Stock
Asset class
Equity
Inception date
02/01/2024
Last close
$32.14
Market cap
$1,070,490,176
Average volume
874500.0
Beta
1.066
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.43